Abstract
Associations of Social Determinants of Health With SGLT2 Inhibitor Use in Kidney Transplant Recipients: A National Study: FR-PO814
Journal of the American Society of Nephrology, Vol.33(11S), pp.546-547
11/2022
DOI: 10.1681/ASN.20223311S1546d
Abstract
Background:
Recent clinical trials demonstrate benefits of SGLT2 inhibitors (SGLT2i) in patients with chronic kidney disease, but data on SGLT2i use in kidney transplant (KTx) recipients are limited.
Methods:
We examined a novel database linking SRTR registry data for KTx recipients (2000-2021) with outpatient fill records from a large pharmaceutical claims warehouse (2015-2021). Adult (age ≥18) KTx recipients treated with SGLT2i were compared to those who received other non-insulin diabetes mediations without SGLT2i. Characteristics associated with SGLT2i use were quantified by multivariable logistic regression (adjusted odds ratio, aOR).
Results:
Among 18,988 KTx recipient treated with non-insulin diabetes agents in the study period, 2,224 filled an SGLT2i. Mean time from KTx to SGLT2i prescription was 6.7 yrs. vs.4.7 yrs. to first captured non-SGLT2i fill. SGLT2i use was more common in adults who were age >30 (compared to age 18-30 yrs.), Asian (aOR, 1.3), or had BMI≥30 (aOR, 1.24), and trended higher with self-pay status (aOR, 1.52). SGLT2i use was lower in patients who were women (aOR, 0.88), Black (aOR, 0.88), other race (aOR, 0.75), publicly insured (aOR, 0.92), or had less than college education (aOR, 0.87). SGLT2i use in KTx patients increased dramatically in 2019-2021 (aOR, 5.64 vs prior yrs). [Figure]
Conclusions:
SGLT2i use is increasing in KTx recipients, but varies with factors including race, education and insurance. While ongoing study is needed to define risks and benefits of SGLT2i use in KTx patients, attention should also focus on reducing treatment disparities related to social determinants of health rather than clinical indications.
Details
- Title: Subtitle
- Associations of Social Determinants of Health With SGLT2 Inhibitor Use in Kidney Transplant Recipients: A National Study: FR-PO814
- Creators
- Krista L. Lentine - Saint Louis UniversityKana N. Miyata - Saint Louis UniversityYasar Caliskan - Saint Louis UniversityNagaraju Sarabu - University Hospitals of ClevelandSandeep Singh Dhindsa Dhindsa - Saint Louis University School of Medicine, Saint Louis, MODavid Axelrod - University of IowaHuiling Xiao - Saint Louis UniversityMara McAdams-DeMarco - New York UniversitySunjae Bae - New York UniversityGregory Hess - Thomas Jefferson UniversityCorey Joseph - Johns Hopkins UniversityDaniel C. Brennan - Johns Hopkins UniversityMark Schnitzler - Saint Louis University
- Resource Type
- Abstract
- Publication Details
- Journal of the American Society of Nephrology, Vol.33(11S), pp.546-547
- DOI
- 10.1681/ASN.20223311S1546d
- ISSN
- 1046-6673
- eISSN
- 1533-3450
- Language
- English
- Date published
- 11/2022
- Academic Unit
- Surgery
- Record Identifier
- 9984649054802771
Metrics
1 Record Views